Nephros develops and sells water solutions. Co. develops and sells water filtration products used in both medical and commercial applications. In medical markets, Co.'s primary filtration mechanism is to pass liquids through the pores of polysulfone hollow fiber. Co.'s filters' pores are smaller than various products, resulting in elimination of waterborne pathogens, including legionella bacteria and viruses. In commercial markets, Co. develops and sells its filters, for which carbon-based absorption is the primary filtration mechanism. These products allow Co. to improve water's odor and taste, to reduce scale and heavy metals, and to reduce other water contaminants for customers. The NEPH stock yearly return is shown above.
The yearly return on the NEPH stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the NEPH annual return calculation with any dividends reinvested as applicable (on ex-dates).
|